Morphine Market is to receive overwhelming hike in Revenues by 2031

Morphine Market: Overview and Dynamics

Morphine is an opioid that is naturally found in plants, animals, and humans. Primarily, morphine is used to treat acute pain and chronic pain by directly acting on the central nervous system (CNS) and decreasing the magnitude of pain. Morphine is grouped in narcotic analgesics which act on the central nervous system to relieve the pain.

Increased demand for morphine in developed countries like the United States and Europe has driven the market growth during the historical period. As per the World Health Organization’s list of essential medicines morphine ranks at 155th most commonly prescribed medicine in the United States.

Morphine is used as an extended-release capsule and extended-release tablets which are used to treat pain. Attributed to its high effectiveness against pain and the aforementioned facts, the global morphine market is poised to embark on a positive growth trajectory, registering a CAGR of ~3% over the forecast period (2020-2030).

On the basis of type, morphine comes in tablets or capsules form. However, growing demand for intravenous morphine injections will experiment significant growth in forthcoming years. Increasing demand in production of other drugs which are hydromorphone, oxymorphone, and heroin is set to augment the market growth.

Get a sample of this report:

Morphine Market: Key Players

Global morphine market is partially consolidated in nature in which top five prominent companies accounts for over one third share of the global production and sales. Currently, Alcaliber S.A, Johnson Matthey Fine Chemicals, Mallinckrodt Pharmaceuticals, Pfizer Inc., Purdue Pharma L.P. and Sun Pharmaceutical Industries Ltd. are the key stakeholders in global morphine market.

The research report presents a comprehensive assessment of the morphine market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The morphine market report provides analysis and information, according to market segments such as geographies, ingredient, type, application and drug type.

Morphine Market: Regional Outlook

The report on the global morphine market covers six major regions that include North America, Europe, Latin America, East Asia, South Asia & Oceania, and MEA. Attributed to huge demand from developed countries for morphine drug as a prescribed medicine for pain treatment has made North America and Europe leading markets in the world.

Alone United States accounted for over one fourth of the global demand due to which North America has driven the consumption of morphine during the historical period. As per The American Cancer Society estimates alone in United States there will be over 10 million people with age of 85 years. In result cancer cases are projected to increase in the same period which will create significant demand for morphine during the forecast period.

Avail customized purchase options

Pre Book this report:

Segmentation Analysis of Morphine Market:

The global morphine market is bifurcated into five major segments: ingredient, type, application, drug type, and region.

On the basis of ingredient, morphine market has been segmented as follows:

  • Morphine Hydrochloride
  • Morphine Sulphate

On the basis of type, morphine market has been segmented as follows:

  • Capsule
  • Injection
  • Oral Tablets
  • Others

On the basis of application, morphine market has been segmented as follows:

  • Hydromorphone
  • Oxymorphone
  • Heroin
  • Others

On the basis of drug type, morphine market has been segmented as follows:

  • Anesthesia
  • Cough Suppressant
  • Diarrhea Suppressant
  • Others

On the basis of geographic regions, morphine market is segmented as

  • North America
  • Europe
  • Latin America
  • East Asia
  • South Asia and Oceania
  • Middle East & Africa

Enquire before buying:

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: [email protected]

Leave a Comment

%d bloggers like this: